These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cholestatic hepatitis due to ticlopidine: clinical and histological recovery after drug withdrawal. Case report and review of the literature. Grieco A; Vecchio FM; Greco AV; Gasbarrini G Eur J Gastroenterol Hepatol; 1998 Aug; 10(8):713-5. PubMed ID: 9744703 [TBL] [Abstract][Full Text] [Related]
3. [Ticlopidine-induced cholestatic hepatitis. A case report]. López P; Castiella A; Bujanda L; Arenas JI Rev Esp Enferm Dig; 1995 Oct; 87(10):735-7. PubMed ID: 8519541 [TBL] [Abstract][Full Text] [Related]
4. [Toxic hepatitis by ticlopidine. Three new cases]. Artímez ML; Fernández E; Rodríguez M; González M; Rodrigo L Rev Esp Enferm Dig; 1997 Oct; 89(10):796-7. PubMed ID: 9424112 [No Abstract] [Full Text] [Related]
9. Inhibition, by drugs, of galactosamine induced hepatitis in the rat. Pickering RW; Lynn James GW; Parker FL Arzneimittelforschung; 1975 Oct; 25(10):1591-2. PubMed ID: 1243044 [TBL] [Abstract][Full Text] [Related]
13. An elderly man with syncytial giant cell hepatitis successfully treated by immunosuppressants. Tajiri K; Shimizu Y; Tokimitsu Y; Tsuneyama K; Sugiyama T Intern Med; 2012; 51(16):2141-4. PubMed ID: 22892492 [TBL] [Abstract][Full Text] [Related]
14. [The joint use of prednisolone and phospholipid-containing hepatoprotectors in experimental chronic hepatitis]. Vengerovskiĭ AI; Golovina EL; Kovalenko MIu; Chuchalin VS; Saprykina EV; Sosnina NV; Burkova VN; Saratikov AS Eksp Klin Farmakol; 1999; 62(2):28-30. PubMed ID: 10340125 [TBL] [Abstract][Full Text] [Related]
15. Clinical use of corticosteroid and immunosuppressive drugs in liver disease. Fung WP Drugs; 1974; 8(2):139-45. PubMed ID: 4434868 [No Abstract] [Full Text] [Related]
16. Drug-induced hepatotoxicity. Podda M; Benetti A Ann Ital Med Int; 2002; 17(4):213-4. PubMed ID: 12532558 [No Abstract] [Full Text] [Related]
17. Autoimmune-like hepatitis during masitinib therapy in an amyotrophic lateral sclerosis patient. Salvado M; Vargas V; Vidal M; Simon-Talero M; Camacho J; Gamez J World J Gastroenterol; 2015 Sep; 21(36):10475-9. PubMed ID: 26420975 [TBL] [Abstract][Full Text] [Related]
18. [A case report of drug induced hepatitis and pancreatitis]. Shimizu A; Koyama M; Miyazaki K; Tagawa S; Takase K; Nakano T; Tameda Y; Kosaka Y Nihon Shokakibyo Gakkai Zasshi; 1997 May; 94(5):351-5. PubMed ID: 9170884 [No Abstract] [Full Text] [Related]
19. Effectiveness and safety of everolimus in the treatment of autoimmune hepatitis related to anti-hepatitis C virus therapy after liver transplant: three case reports. Casanovas T; Argudo A; Peña-Cala MC Transplant Proc; 2011; 43(6):2233-6. PubMed ID: 21839242 [TBL] [Abstract][Full Text] [Related]
20. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy. Manousou P; Samonakis D; Cholongitas E; Patch D; O'Beirne J; Dhillon AP; Rolles K; McCormick A; Hayes P; Burroughs AK Liver Transpl; 2009 Dec; 15(12):1783-91. PubMed ID: 19938143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]